<DOC>
	<DOC>NCT00835380</DOC>
	<brief_summary>This study will demonstrate the immunogenicity and evaluate the safety/tolerability of the vaccine in Chinese children between 12 and 23 months of age.</brief_summary>
	<brief_title>A Study of 2 Doses of VAQTAâ„¢ in Healthy Children 12 to 23 Months of Age (V251-069)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Chinese children 12 to 17 months old at receipt of the first study vaccination Subject is Hepatitis A virus antibody positive at screening or has a history of Hepatitis A infection Subject has a fever 72 hours prior to first injection Subject has already been vaccinated for Hepatitis A Subject is allergic to aluminum, formaldehyde, sodium borate, latex, or any component of the vaccine Subject has received inactivated vaccines within 14 days of screening or live vaccines within 30 days of screening</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>